Novel LOVD databases for hereditary breast cancer and colorectal cancer genes in the Chinese population-Reference-Cited by-同舟云学术

Novel LOVD databases for hereditary breast cancer and colorectal cancer genes in the Chinese population

Published:2011-10-20 Issue:12 Volume:32 Page:1335-1340
ISSN:1059-7794
Container-title:Human Mutation
language:en
Short-container-title:Hum. Mutat.

Author:

Pan Min,Cong Peikuan,Wang Yue,Lin Changsong,Yuan Ying,Dong Jian,Banerjee Santasree,Zhang Tao,Chen Yanling,Zhang Ting,Chen Mingqing,Hu Peter,Zheng Shu,Zhang Jin,Qi Ming

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Reference32 articles.

1. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women;Abeliovich;Am J Hum Genet,1997

2. The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim;Bar-Sade;Hum Mol Genet,1998

3. BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer;Chen;Breast Cancer Res Treat,2009

4. China spurs quest for human variome;Cyranoski;Nature,2011

5. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion;den Dunnen;Hum Mutat,2000

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive LOVD Database for Fatty Acid Oxidation Disorders in Chinese Populations;Human Mutation;2023-07-25

2. A Collaborative Effort to Define Classification Criteria for ATM Variants in Hereditary Cancer Patients;Clinical Chemistry;2020-11-30

3. LOVD–DASH: A comprehensive LOVD database coupled with diagnosis and an at‐risk assessment system for hemoglobinopathies;Human Mutation;2019-09-11

4. Towards the automated economic assessment of newborn screening for rare diseases;Journal of Biomedical Informatics;2019-07

5. Impact of germline CHEK2 mutations on biochemical relapse free survival and metastasis free survival after radical treatment for patients with prostate cancer;Cancer Urology;2019-01-15